Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Lipton

Showing results (951-960 of 1,173) with videos related to

Pageof 118
Sort By:
Medrxiv : the Preprint Server for Health Sciences|September 5, 2025
Prognostic Value of Plasma Glial Fibrillary Acidic Protein in Cognitively Unimpaired Older Adults: Results from the A4 StudyElham Ghanbarian, Tianchen Qian, Babak Khorsand, et al.
Headache|June 19, 2015
Clinical Pain Catastrophizing in Women With Migraine and ObesityDale S Bond, Dawn C Buse, Richard B Lipton, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|September 22, 2012
A randomized controlled trial of a comprehensive migraine intervention prior to discharge from an emergency departmentBenjamin W Friedman, Clemencia Solorzano, Jennifer Norton, et al.
Headache|December 15, 2025
OnabotulinumtoxinA treatment among diverse racial groups: Post hoc analysis of the phase 4 Chronic migraine OnabotulinuMtoxinA Prolonged Efficacy open-Label (COMPEL) trialAndrew M Blumenfeld, Larry Charleston, Deena Kuruvilla, et al.
Cephalalgia : an International Journal of Headache|December 9, 2024
Effect of preventive treatment with atogepant on quality of life, daily functioning, and headache impact across the spectrum of migraine: Findings from three double-blind, randomized, phase 3 trialsChristopher Gottschalk, Pranav Gandhi, Patricia Pozo-Rosich, et al.
Journal of Psychosomatic Research|September 10, 2023
Older adults' self-reported prospective memory lapses in everyday life: Connections to inflammation and genderErin E Harrington, Jennifer E Graham-Engeland, Martin J Sliwinski, et al.
The Journal of Headache and Pain|February 8, 2022
Eptinezumab treatment initiated during a migraine attack is associated with meaningful improvement in patient-reported outcome measures: secondary results from the randomized controlled RELIEF studyPeter McAllister, Paul K Winner, Jessica Ailani, et al.
The Journal of Headache and Pain|July 14, 2010
Migraine is comorbid with multiple sclerosis and associated with a more symptomatic MS courseIlya Kister, A B Caminero, T S Monteith, et al.
The Journal of Headache and Pain|August 19, 2024
Characterizing barriers to care in migraine: multicountry results from the Chronic Migraine Epidemiology and Outcomes - International (CaMEO-I) studyMichel Lanteri-Minet, Elizabeth Leroux, Zaza Katsarava, et al.
Annals of Emergency Medicine|January 11, 2007
Applying the International Classification of Headache Disorders to the emergency department: an assessment of reproducibility and the frequency with which a unique diagnosis can be assigned to every acute headache presentationBenjamin W Friedman, Michael L Hochberg, David Esses, et al.
Pageof 118

Showing results (951-960 of 1,173) with videos related to

Sort By:
Pageof 118
Medrxiv : the Preprint Server for Health Sciences|September 5, 2025
Prognostic Value of Plasma Glial Fibrillary Acidic Protein in Cognitively Unimpaired Older Adults: Results from the A4 StudyElham Ghanbarian, Tianchen Qian, Babak Khorsand, et al.
Headache|June 19, 2015
Clinical Pain Catastrophizing in Women With Migraine and ObesityDale S Bond, Dawn C Buse, Richard B Lipton, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|September 22, 2012
A randomized controlled trial of a comprehensive migraine intervention prior to discharge from an emergency departmentBenjamin W Friedman, Clemencia Solorzano, Jennifer Norton, et al.
Headache|December 15, 2025
OnabotulinumtoxinA treatment among diverse racial groups: Post hoc analysis of the phase 4 Chronic migraine OnabotulinuMtoxinA Prolonged Efficacy open-Label (COMPEL) trialAndrew M Blumenfeld, Larry Charleston, Deena Kuruvilla, et al.
Cephalalgia : an International Journal of Headache|December 9, 2024
Effect of preventive treatment with atogepant on quality of life, daily functioning, and headache impact across the spectrum of migraine: Findings from three double-blind, randomized, phase 3 trialsChristopher Gottschalk, Pranav Gandhi, Patricia Pozo-Rosich, et al.
Journal of Psychosomatic Research|September 10, 2023
Older adults' self-reported prospective memory lapses in everyday life: Connections to inflammation and genderErin E Harrington, Jennifer E Graham-Engeland, Martin J Sliwinski, et al.
The Journal of Headache and Pain|February 8, 2022
Eptinezumab treatment initiated during a migraine attack is associated with meaningful improvement in patient-reported outcome measures: secondary results from the randomized controlled RELIEF studyPeter McAllister, Paul K Winner, Jessica Ailani, et al.
The Journal of Headache and Pain|July 14, 2010
Migraine is comorbid with multiple sclerosis and associated with a more symptomatic MS courseIlya Kister, A B Caminero, T S Monteith, et al.
The Journal of Headache and Pain|August 19, 2024
Characterizing barriers to care in migraine: multicountry results from the Chronic Migraine Epidemiology and Outcomes - International (CaMEO-I) studyMichel Lanteri-Minet, Elizabeth Leroux, Zaza Katsarava, et al.
Annals of Emergency Medicine|January 11, 2007
Applying the International Classification of Headache Disorders to the emergency department: an assessment of reproducibility and the frequency with which a unique diagnosis can be assigned to every acute headache presentationBenjamin W Friedman, Michael L Hochberg, David Esses, et al.
Pageof 118